Skip to content

R&D at other companies

AngioDynamics logo
AngioDynamicsANGO
$7.08M+2.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$22.61M+0.6%
Solventum logo
SolventumSOLV
$189M-2.1%
MiMedx Group logo
MiMedx GroupMDXG
$4.14M+24.4%
United Therapeutics logo
United TherapeuticsUTHR
$138.2M-7.2%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$15.16M+42.5%

Other financials

Income statement

See full
Revenue$75.3M+22.8%
Gross profit$57.6M+27.1%
Operating income-$1.5M+66.2%
Net income-$1.8M+40.7%
EPS (diluted)-$0.08+38.5%

Balance sheet

See full
Cash & equivalents$75.0M-10.3%
Total debt$15.2M-62.7%
Total equity$217.9M+5.9%
Total assets$272.1M-2.9%

Cash flow

See full
Operating cash flow-$339.0K-181%
CapEx$821.0K+117%
Free cash flow-$1.2M-3,153%

Valuation

See full
Market cap$631.58M+172%
Enterprise value$571.76M+203%
P/E31.1×+16.8×
P/S1.8×+1.0×

Profitability

See full
Gross margin76.4%+1.8pp
Operating margin9.4%+2.4pp
Net margin5.9%+0.4pp
FCF margin11.4%-1.5pp

Returns & leverage

See full
Return on equity9.6%+1.5pp
Debt / equity0.1×-0.1×
Current ratio4.2×-0.3×

Where this comes from

Reported directly by Tactile Systems Technology in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Tactile Systems Technology’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tactile Systems Technology's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tactile Systems Technology's R&D?
Tactile Systems Technology (TCMD) reported R&D of $2.78M in Q1 2026.
How has Tactile Systems Technology's R&D changed year-over-year?
Tactile Systems Technology's R&D increased by 59.4% year-over-year, from $1.74M to $2.78M.
What is the long-term trend for Tactile Systems Technology's R&D?
Over 4 years (2021 to 2025), Tactile Systems Technology's R&D has grown at a 10.6% compound annual growth rate (CAGR), from $5.66M to $8.48M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.